Duran, E. Et Al. 2022. CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED >= 60 YEARS. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 1336.

Duran, E., Unaldi, E., Bilgin, E., Bolek, E. C., Yardimci, G. K., Farisogullari, B., ... Ozsoy, Z.(2022). CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED >= 60 YEARS. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1336.

Duran, E. Et Al. "CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED >= 60 YEARS," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1336, 2022

Duran, E. Et Al. "CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED >= 60 YEARS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1336, 2022

Duran, E. Et Al. (2022) . "CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED >= 60 YEARS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, p.1336.

@article{article, author={E. Duran Et Al. }, title={CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED >= 60 YEARS}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1336} }